Volume 27, Issue 1 (Iranian South Medical Journal 2024)
Iran South Med J 2024, 27(1): 26-36 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eslami F, Pouyannia A, Talebi S S, Doosti-Irani A. Prevalence of Meibomian Gland Dysfunction & Dry Eye Syndrome in Patients with Diabetes: A Cross-Sectional Study. Iran South Med J 2024; 27 (1) :26-36
URL: http://ismj.bpums.ac.ir/article-1-1983-en.html
URL: http://ismj.bpums.ac.ir/article-1-1983-en.html
1- Department of Ophthalmology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Epidemiology, School of Public Health, Hamadan University of Medical Science, Hamadan, Iran ,A.doosti@umsha.ac.ir
2- Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Epidemiology, School of Public Health, Hamadan University of Medical Science, Hamadan, Iran ,
Abstract: (126 Views)
Background: Diabetes, as the most common disease caused by metabolic disorders, is associated with several compli-cations, including ocular complications. The aim of this cross-sectional study was to determine the fre-quency of meibomian gland dysfunction and dry eye in patients with diabetes.
Materials and Methods: In this descriptive-analytical cross-sectional study, patients with type 2 diabetes referred to the eye clinic of Farshchian Hospital (Sina) from December 2019 to October 2020 were included. Data were collected on the patients’ demographic characteristics, duration of diabetes, and HbA1c using a pre-designed checklist. The severity of dry eye was assessed by the tear breakup time (TBUT) test, while meibomian gland disorder and ocular complications were evaluated by a slit lamp.
Results: In this study, 267 patients with type 2 diabetes participated. The mean age of the patients was 59.8 years, and 44.2% of them were male. Mild, moderate, and severe dry eye were observed in 34.1%, 18.0% and 5.2% of the patients, respectively. Grades 1, 2, and 3 of meibomian gland dysfunction were observed in 32.6%, 15.7%, and 5.2% of the patients respectively. Patients with poor glycemic control had higher se-verity of dry eye (p<0.001) and more meibomian gland dysfunction (p<0.001).
Conclusion: Dry eye and meibomian gland dysfunction have a high prevalence in patients with diabetes mellitus, and more severe dry eye and meibomian gland dysfunction are associated with poor glycemic control and longer duration of diabetes diagnosis.
Materials and Methods: In this descriptive-analytical cross-sectional study, patients with type 2 diabetes referred to the eye clinic of Farshchian Hospital (Sina) from December 2019 to October 2020 were included. Data were collected on the patients’ demographic characteristics, duration of diabetes, and HbA1c using a pre-designed checklist. The severity of dry eye was assessed by the tear breakup time (TBUT) test, while meibomian gland disorder and ocular complications were evaluated by a slit lamp.
Results: In this study, 267 patients with type 2 diabetes participated. The mean age of the patients was 59.8 years, and 44.2% of them were male. Mild, moderate, and severe dry eye were observed in 34.1%, 18.0% and 5.2% of the patients, respectively. Grades 1, 2, and 3 of meibomian gland dysfunction were observed in 32.6%, 15.7%, and 5.2% of the patients respectively. Patients with poor glycemic control had higher se-verity of dry eye (p<0.001) and more meibomian gland dysfunction (p<0.001).
Conclusion: Dry eye and meibomian gland dysfunction have a high prevalence in patients with diabetes mellitus, and more severe dry eye and meibomian gland dysfunction are associated with poor glycemic control and longer duration of diabetes diagnosis.
Type of Study: Original |
Subject:
Ophthalmology
Received: 2023/03/1 | Accepted: 2024/07/17 | Published: 2024/10/28
Received: 2023/03/1 | Accepted: 2024/07/17 | Published: 2024/10/28
References
1. De Freitas GR, Ferraz GAM, Gehlen M, et al. Dry eyes in patients with diabetes mellitus. Prim Care Diabetes 2021; 15(1): 184-6. [DOI]
2. Seewoodhary M. An overview of diabetic retinopathy and other ocular complications of diabetes mellitus. Nurs Stand 2021; 36(7): 71-6. [DOI]
3. Zhang X, Zhao L, Deng S, et al. Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics. J Ophthalmol 2016; 2016: 8201053. [DOI]
4. Yoo TK, Oh E. Diabetes mellitus is associated with dry eye syndrome: a meta-analysis. Int Ophthalmol 2019; 39(11): 2611-20. [DOI]
5. Shamsheer RP, Arunachalam C. A Clinical Study of Meibomian Gland Dysfunction in Patients with Diabetes. Middle East Afr J Ophthalmol 2015; 22(4): 462-6. [DOI]
6. Sandra Johanna GP, Antonio LA, Andrés GS. Correlation between type 2 diabetes, dry eye and Meibomian glands dysfunction. J Optom 2019; 12(4): 256-62. [DOI]
7. Wu H, Fang X, Luo S, et al. Meibomian Glands and Tear Film Findings in Type 2 Diabetic Patients: A Cross-Sectional Study. Front Med (Lausanne) 2022; 9: 762493. [DOI]
8. Lin X, Xu B, Zheng Y, et al. Meibomian Gland Dysfunction in Type 2 Diabetic Patients. J Ophthalmol 2017; 2017: 3047867. [DOI]
9. Yaqubi G, Shokoohi Rad S, Hooshyar H, et al. The Prevalence Dry Eye Among Attendant of Birjand Valiaser Hospital from 2009-2010. Bina j ophthalmol 2012; 17(4): 345-50. (persian) [Article]
10. Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol 2011; 152: 377-84. [DOI]
11. Pan L-Y, Kuo Y-K, Chen T-H, et al. Dry eye disease in patients with type II diabetes mellitus: A retrospective, population-based cohort study in Taiwan. Front Med (Lausanne) 2022; 9: 980714. [DOI]
12. Tang Y-L, Cheng Y-L, Ren Y-P, et al. Metabolic syndrome risk factors and dry eye syndrome: a metaanalysis. Int J Ophthalmol 2016; 9: 1038-45. [DOI]
13. Uchino M, Nishiwaki Y, Michikawa T, K et al. Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology 2011; 118(12): 2361-7. [DOI]
14. Beckman KA. Characterization of dry eye disease in diabetic patients versus nondiabetic patients. Cornea 2014; 33(8): 851-4. [DOI]
15. DeMill DL, Hussain M, Pop-Busui R, et al. Ocular surface disease in patients with diabetic peripheral neuropathy. Br J Ophthalmol 2016; 100(7): 924-8. [DOI]
16. Lin X, Xu B, Zheng Y, et al. Meibomian gland dysfunction in type 2 diabetic patients. J Ophthalmol 2017; 2017: 3047867. [DOI]
17. Baek J, Doh SH, SK C. Assessment of the tear meniscus using optical coherence tomography in patients with type 2 diabetes mellitus. Cornea 2015; 34(12): 1534-40. [DOI]
18. Eissa IM, Khalil NM, HA E-G. A controlled study on the correlation between tear film volume and tear film stability in diabetic patients. J Ophthalmol 2016; 2016: 5465272. [DOI]
19. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001; 108(3): 586-92. [DOI]
20. Zhmud ТМ, Malachkova NV, Andrushkova OO, et al. Meibomian Gland dysfunction and dry eye disease symptoms in patients with type 2 Diabetes Mellitus. Reports of Morphology 2019; 25(4): 51-5. [Article]
21. Viso E, Gude F, MT Rg-A. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea 2011; 30(1): 1-6. [DOI]
22. Yuanyuan Z, Xuemei L, Yuanyuan Q, et al. Meibomian gland dysfunction and expressions of inflammatory factors and lipid metabolic factors in diabetic mice. CJEO 2022: 820-6. [Article]
23. Liu J, Shi B, He S, et al. Changes to tear cytokines of type 2 diabetic patients with or without retinopathy. Mol Vis 2010; 16: 2931-8. [Article]
24. Chen E, Looman M, Laouri M, et al. Burden of illness of diabetic macular edema: literature review. Curr Med Res Opin 2010; 26(7): 1587-97. [DOI]
25. Farshchi A, Esteghamati A, Sari AA, et al. The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus. J Diabetes Metab Disord 2014; 13(1): 42. [DOI]
26. Heidari Z, Sharafi Z. Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study. Iran South Med J 2022; 25(1): 30-41. (Persian) [DOI]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
